Literature DB >> 6974768

Positron imaging feasibility studies. II: Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communication.

S M Larson, P L Weiden, Z Grunbaum, H G Kaplan, J S Rasey, M M Graham, G E Sale, G D Harp, D L Williams.   

Abstract

Uptake of [3H]2-deoxyglucose was studied in BALB/c mice with EMT-6 sarcoma, in Buffalo rats with Morris 7777 hepatoma, and in eight dogs with spontaneous neoplasms: five osteosarcomas and three diffuse lymphomas. High tumor-to-tissue ratios were observed for all tumor types studied. In rodents, peak levels of uptake occurred between 30 min and 1 hr, with a slow loss from the tumor of about 10% per hour thereafter. In dogs there was considerable variability in uptake, both between individuals and at different tumor sites within an individual. Necrotic tumor did not take up the radiotracer. Absolute uptakes, when normalized for body weight, were similar for spontaneous and transplanted neoplasms. These studies provide additional support for the concept that positron emission tomography can be used to obtain functional images of important metabolic processes of tumors, including glycolysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6974768

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Effectiveness of positron emission tomography for the detection of melanoma metastases.

Authors:  W D Holder; R L White; J H Zuger; E J Easton; F L Greene
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

2.  Coincidence of Malignant Melanoma and an Incidently Discovered Parotid Mass Presenting a Diagnostic Challenge.

Authors:  Handan Derebaşinlioğlu; Sarper Yilmaz
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-08-07

3.  18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.

Authors:  H Joensuu; A Ahonen; P J Klemi
Journal:  Eur J Nucl Med       Date:  1988

4.  Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.

Authors:  Stefanie M F Seiler; Christine Baumgartner; Johannes Hirschberger; Ambros J Beer; Andreas Brühschwein; Nina Kreutzmann; Silja Laberke; Melanie C Wergin; Andrea Meyer-Lindenberg; Johanna Brandl; Anne-Kathrin von Thaden; Eliane Farrell; Markus Schwaiger
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

5.  Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.

Authors:  Antonella Borgatti; Amber L Winter; Kathleen Stuebner; Ruth Scott; Christopher P Ober; Kari L Anderson; Daniel A Feeney; Daniel A Vallera; Joseph S Koopmeiners; Jaime F Modiano; Jerry Froelich
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.